Rep. Glenn Grothman @RepGrothman
In the current system, patients prescribed expensive brand-name insulin either pay-up or forego the medication keeping them alive. My bill will give them options by making safe biosimilar (generic) insulin products more readily available at lower costs. https://t.co/L1hjNwNsw8 — PolitiTweet.org